Breast cancer patients with higher BMI more likely to experience heart damage during chemotherapy
Breast cancer survival rates have improved considerably in the last few decades in Colombia, but factors that increase the likelihood of patients experiencing cardiovascular side effects, like cardiotoxicity, are not well-known or well-treated. A recent study in the North-East region of Colombia found 11.94% of patients with a high BMI being treated for breast cancer at a regional center experienced heart damage, or cardiotoxicity, during chemotherapy. The study will be presented at the American College of Cardiology (ACC) Latin America 2023 Together with Asociación Costarricense ...











